Delivery Order SPE2DB20D2104-SPE2DB25FMXPQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,871.55 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat inflammatory...
- The Defense Logistics Agency (DLA) awarded a $31,833.56 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,383.13 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Syringe on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication commonly used to treat inflammatory conditions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector medication, valued at $3,320.62 with a firm fixed price structure. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive, non-set-aside delivery order. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $9,973.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical product, with an ultimate completion date of July 30, 2025. This is a non-set-aside award issued on July 29, 2025, with fulfillment based at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $11,239.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies. The contract, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,641.24 to AmerisourceBergen Drug Corp for TALTZ 40 mg/0.5 mL syringes on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat autoimmune conditions...
- The Defense Logistics Agency awarded a $24,342.24 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) units, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $4,133.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/mL auto-injector medication, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXPQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,761.96 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml syringes. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products and medical supplies through competitively awarded, firm fixed-price delivery orders with the DLA. TALTZ (ixekizumab), a biologic immunosuppressant typically used for treating autoimmune inflammatory conditions, represents part of the specialty pharmaceutical medications supplied through the vendor's comprehensive federal contract vehicle supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/12/25 |